Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
2.800
-0.100 (-3.45%)
At close: Jan 12, 2026, 4:00 PM EST
2.880
+0.080 (2.86%)
Pre-market: Jan 13, 2026, 9:07 AM EST
Treace Medical Concepts Market Cap
Treace Medical Concepts has a market cap or net worth of $178.41 million as of January 13, 2026. Its market cap has decreased by -58.91% in one year.
Market Cap
178.41M
Enterprise Value
191.37M
1-Year Change
-58.91%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since the IPO on April 23, 2021, Treace Medical Concepts's market cap has decreased from $889.74M to $178.41M, a decrease of -79.95%. That is a compound annual growth rate of -28.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 178.41M | 14.29% |
| Dec 31, 2025 | 156.11M | -66.32% |
| Dec 31, 2024 | 463.49M | -41.06% |
| Dec 29, 2023 | 786.37M | -38.37% |
| Dec 30, 2022 | 1.28B | 28.74% |
| Dec 31, 2021 | 991.14M | 11.40% |
| Apr 23, 2021 | 889.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |